Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 24, Number 4—April 2018

Research

Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence

C. Raina MacIntyre, Valentina CostantinoComments to Author , Xin Chen, Eva Segelov, Abrar Ahmad Chughtai, Anthony Kelleher, Mohana Kunasekaran, and John Michael Lane
Author affiliations: School of Public Health and Community Medicine, University of New South Wales, Sydney, New South Wales, Australia (C.R. MacIntyre, V. Costantino, X. Chen, A.A. Chughtai, M. Kunasekaran); Arizona State University, Phoenix, Arizona, USA (C.R. MacIntyre); Monash University and Monash Health, Melbourne, Victoria, Australia (E. Segelov); Kirby Institute, University of New South Wales, Sydney (A. Kelleher); Emory University, Atlanta, Georgia, USA (J.M. Lane)

Main Article

Figure 2

Smallpox infection and death rates of population for base case scenario and for scenario including immunosuppression in model, by age group, New York, NY, USA, and Sydney, New South Wales, Australia. Characteristics (e.g., size, age, immunosuppression rates) of populations from 2015 were used. A) Infection rate 50 and 60 days after start of smallpox outbreak; B) cumulative deaths in population 50 and 60 days after start of smallpox outbreak.

Figure 2. Smallpox infection and death rates of population for base case scenario and for scenario including immunosuppression in model, by age group, New York, NY, USA, and Sydney, New South Wales, Australia. Characteristics (e.g., size, age, immunosuppression rates) of populations from 2015 were used. A) Infection rate 50 and 60 days after start of smallpox outbreak; B) cumulative deaths in population 50 and 60 days after start of smallpox outbreak.

Main Article

Page created: March 20, 2018
Page updated: March 20, 2018
Page reviewed: March 20, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external